Chad Messer
Stock Analyst at Lake Street
(3.11)
# 2,854
Out of 4,457 analysts
531
Total ratings
40.3%
Success rate
2%
Average return
Main Sectors:
Stocks Rated by Chad Messer
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MNPR Monopar Therapeutics | Maintained: Buy | $103 | $94.56 | +8.93% | 7 | Jun 30, 2026 | |
| GNLX Genelux | Maintained: Buy | $16 | $3.01 | +431.56% | 6 | Jun 30, 2026 | |
| CGEN Compugen | Reiterated: Buy | $6 → $5 | $2.16 | +131.48% | 3 | Jun 24, 2026 | |
| KZIA Kazia Therapeutics | Initiated Coverage: Buy | $32 | $14.46 | +121.30% | 1 | Jun 11, 2026 | |
| OSTX OS Therapies | Maintained: Buy | $13 | $1.91 | +580.63% | 18 | Jun 3, 2026 | |
| ONCY Oncolytics Biotech | Maintained: Buy | $5 | $0.96 | +420.83% | 18 | Jun 1, 2026 | |
| IMNM Immunome | Maintained: Buy | $30 | $21.13 | +42.01% | 9 | Jun 1, 2026 | |
| COYA Coya Therapeutics | Maintained: Buy | $17 | $6.06 | +180.53% | 14 | May 22, 2026 | |
| PSTV Plus Therapeutics | Maintained: Buy | $50 | $4.25 | +1,076.47% | 5 | May 19, 2026 | |
| LTRN Lantern Pharma | Maintained: Buy | $25 | $4.07 | +514.25% | 13 | May 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $75 | $3.91 | +1,820.61% | 6 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $19.21 | - | 1 | Apr 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $6 → $7 | $9.64 | n/a | 18 | Nov 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | kr 340.00 → kr 380.00 | $180.00 | n/a | 13 | Sep 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $3 | $1.32 | n/a | 17 | Aug 17, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $29 | $7.67 | n/a | 7 | Aug 13, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $49 | $6.87 | n/a | 5 | Aug 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $5 | $0.0001 | n/a | 11 | Aug 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $50 | $102.54 | n/a | 2 | Aug 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $48 | $87.31 | n/a | 31 | Aug 6, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $30 | $1.87 | n/a | 13 | Aug 6, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $10 | $1.20 | n/a | 17 | Aug 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $12 | $91.51 | n/a | 19 | Aug 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $21 | $1.65 | n/a | 17 | Aug 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $45.26 | n/a | 25 | Aug 4, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $84 | $81.30 | n/a | 50 | Aug 4, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $134 → $114 | $3.16 | n/a | 34 | Aug 3, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $6 | $0.0001 | n/a | 17 | Jul 29, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $48 | $23.80 | n/a | 6 | Jul 15, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $33 → $30 | $54.70 | n/a | 22 | Jun 28, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $75 → $83 | $1.93 | n/a | 4 | Jun 7, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $166 | $17.33 | n/a | 50 | May 18, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $10 | $0.3178 | n/a | 2 | May 14, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $37.91 | n/a | 21 | May 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $4.41 | n/a | 3 | Nov 8, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $30 → $27 | $14.45 | n/a | 3 | Apr 12, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $6 → $33 | $6.22 | n/a | 10 | Dec 9, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 → $7 | $0.00004 | n/a | 5 | May 7, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $7 → $4 | $15.74 | n/a | 6 | Mar 6, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $17 | $1.65 | n/a | 1 | Jan 5, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $5 | $2.15 | n/a | 1 | May 22, 2012 |
Monopar Therapeutics
Jun 30, 2026
Maintained: Buy
Price Target: $103
Current: $94.56
Upside: +8.93%
Genelux
Jun 30, 2026
Maintained: Buy
Price Target: $16
Current: $3.01
Upside: +431.56%
Compugen
Jun 24, 2026
Reiterated: Buy
Price Target: $6 → $5
Current: $2.16
Upside: +131.48%
Kazia Therapeutics
Jun 11, 2026
Initiated Coverage: Buy
Price Target: $32
Current: $14.46
Upside: +121.30%
OS Therapies
Jun 3, 2026
Maintained: Buy
Price Target: $13
Current: $1.91
Upside: +580.63%
Oncolytics Biotech
Jun 1, 2026
Maintained: Buy
Price Target: $5
Current: $0.96
Upside: +420.83%
Immunome
Jun 1, 2026
Maintained: Buy
Price Target: $30
Current: $21.13
Upside: +42.01%
Coya Therapeutics
May 22, 2026
Maintained: Buy
Price Target: $17
Current: $6.06
Upside: +180.53%
Plus Therapeutics
May 19, 2026
Maintained: Buy
Price Target: $50
Current: $4.25
Upside: +1,076.47%
Lantern Pharma
May 18, 2026
Maintained: Buy
Price Target: $25
Current: $4.07
Upside: +514.25%
May 13, 2026
Maintained: Buy
Price Target: $75
Current: $3.91
Upside: +1,820.61%
Apr 30, 2026
Reiterated: Buy
Price Target: n/a
Current: $19.21
Upside: -
Nov 1, 2021
Maintained: Buy
Price Target: $6 → $7
Current: $9.64
Upside: n/a
Sep 1, 2021
Reiterated: Buy
Price Target: kr 340.00 → kr 380.00
Current: $180.00
Upside: n/a
Aug 17, 2021
Rated: Buy
Price Target: $3
Current: $1.32
Upside: n/a
Aug 13, 2021
Maintained: Buy
Price Target: $29
Current: $7.67
Upside: n/a
Aug 12, 2021
Maintained: Buy
Price Target: $49
Current: $6.87
Upside: n/a
Aug 10, 2021
Maintained: Buy
Price Target: $5
Current: $0.0001
Upside: n/a
Aug 10, 2021
Rated: Buy
Price Target: $50
Current: $102.54
Upside: n/a
Aug 6, 2021
Rated: Buy
Price Target: $48
Current: $87.31
Upside: n/a
Aug 6, 2021
Rated: Buy
Price Target: $30
Current: $1.87
Upside: n/a
Aug 5, 2021
Rated: Buy
Price Target: $10
Current: $1.20
Upside: n/a
Aug 5, 2021
Rated: Buy
Price Target: $12
Current: $91.51
Upside: n/a
Aug 5, 2021
Rated: Buy
Price Target: $21
Current: $1.65
Upside: n/a
Aug 4, 2021
Rated: Hold
Price Target: n/a
Current: $45.26
Upside: n/a
Aug 4, 2021
Rated: Buy
Price Target: $84
Current: $81.30
Upside: n/a
Aug 3, 2021
Rated: Buy
Price Target: $134 → $114
Current: $3.16
Upside: n/a
Jul 29, 2021
Rated: Buy
Price Target: $6
Current: $0.0001
Upside: n/a
Jul 15, 2021
Rated: Buy
Price Target: $48
Current: $23.80
Upside: n/a
Jun 28, 2021
Maintained: Buy
Price Target: $33 → $30
Current: $54.70
Upside: n/a
Jun 7, 2021
Reiterated: Buy
Price Target: $75 → $83
Current: $1.93
Upside: n/a
May 18, 2021
Reiterated: Buy
Price Target: $166
Current: $17.33
Upside: n/a
May 14, 2021
Rated: Buy
Price Target: $10
Current: $0.3178
Upside: n/a
May 10, 2021
Rated: Hold
Price Target: n/a
Current: $37.91
Upside: n/a
Nov 8, 2019
Rated: Hold
Price Target: n/a
Current: $4.41
Upside: n/a
Apr 12, 2018
Maintained: Buy
Price Target: $30 → $27
Current: $14.45
Upside: n/a
Dec 9, 2016
Reiterated: Buy
Price Target: $6 → $33
Current: $6.22
Upside: n/a
May 7, 2015
Reiterated: Buy
Price Target: $10 → $7
Current: $0.00004
Upside: n/a
Mar 6, 2015
Maintained: Buy
Price Target: $7 → $4
Current: $15.74
Upside: n/a
Jan 5, 2015
Initiated Coverage: Buy
Price Target: $17
Current: $1.65
Upside: n/a
May 22, 2012
Initiated Coverage: Buy
Price Target: $5
Current: $2.15
Upside: n/a